These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12936981)

  • 21. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.
    Kern WV; Oethinger M; Jellen-Ritter AS; Levy SB
    Antimicrob Agents Chemother; 2000 Apr; 44(4):814-20. PubMed ID: 10722475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
    Abouzeed YM; Baucheron S; Cloeckaert A
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2428-34. PubMed ID: 18443112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efflux pumps AcrAB and OqxAB contribute to nitrofurantoin resistance in an uropathogenic Klebsiella pneumoniae isolate.
    Xu Q; Jiang J; Zhu Z; Xu T; Sheng ZK; Ye M; Xu X; Wang M
    Int J Antimicrob Agents; 2019 Aug; 54(2):223-227. PubMed ID: 31200021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae.
    Piddock LJ; Johnson MM; Simjee S; Pumbwe L
    Antimicrob Agents Chemother; 2002 Mar; 46(3):808-12. PubMed ID: 11850265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae.
    Rosenblum R; Khan E; Gonzalez G; Hasan R; Schneiders T
    Int J Antimicrob Agents; 2011 Jul; 38(1):39-45. PubMed ID: 21514798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204.
    Baucheron S; Imberechts H; Chaslus-Dancla E; Cloeckaert A
    Microb Drug Resist; 2002; 8(4):281-9. PubMed ID: 12523625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant prevention concentrations for single-step fluoroquinolone-resistant mutants of wild-type, efflux-positive, or ParC or GyrA mutation-containing Streptococcus pneumoniae isolates.
    Smith HJ; Walters M; Hisanaga T; Zhanel GG; Hoban DJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3954-8. PubMed ID: 15388458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo evolution of tigecycline-non-susceptible Klebsiella pneumoniae strains in patients: relationship between virulence and resistance.
    Lin YT; Huang YW; Huang HH; Yang TC; Wang FD; Fung CP
    Int J Antimicrob Agents; 2016 Nov; 48(5):485-491. PubMed ID: 27575728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels.
    Källman O; Motakefi A; Wretlind B; Kalin M; Olsson-Liljequist B; Giske CG
    J Antimicrob Chemother; 2008 Nov; 62(5):986-90. PubMed ID: 18647746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae.
    Ruzin A; Immermann FW; Bradford PA
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3430-2. PubMed ID: 18625776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and role of efflux pump activity in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae.
    Aathithan S; French GL
    Eur J Clin Microbiol Infect Dis; 2011 Jun; 30(6):745-52. PubMed ID: 21286930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin.
    Payot S; Cloeckaert A; Chaslus-Dancla E
    Microb Drug Resist; 2002; 8(4):335-43. PubMed ID: 12523631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae.
    Ruzin A; Visalli MA; Keeney D; Bradford PA
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1017-22. PubMed ID: 15728897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of tigecycline-resistant Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
    Goodarzi R; Arabestani M; Alikhani MY; Keramat F; Asghari B
    J Infect Dev Ctries; 2021 Nov; 15(11):1677-1684. PubMed ID: 34898496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli.
    Oethinger M; Podglajen I; Kern WV; Levy SB
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2089-94. PubMed ID: 9687412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of overproducing the AraC-type transcriptional regulators MarA, SoxS, RarA and RamA on antimicrobial drug susceptibility in Klebsiella pneumoniae.
    Jiménez-Castellanos JC; Wan Ahmad Kamil WN; Cheung CH; Tobin MS; Brown J; Isaac SG; Heesom KJ; Schneiders T; Avison MB
    J Antimicrob Chemother; 2016 Jul; 71(7):1820-5. PubMed ID: 27029850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence and characterization of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae isolates from blood samples of patients in intensive care units in northern China.
    Xu H; Zhou Y; Zhai X; Du Z; Wu H; Han Y; Huo C; Chen Y
    J Med Microbiol; 2016 Aug; 65(8):751-759. PubMed ID: 27324378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.